Cholesgen

AstraZeneca returns to hypercholesterolemia via R&D pact with fresh-faced Chinese biotech
Fierce Biotech
Fri, 06/16/23 - 09:59 am
AstraZeneca
hypercholesterolemia
R&D
Cholesgen